PRECISION TESTING PLATFORM FOR THE DETECTION OF VIRAL-INDUCED CANCERS

NP Screen™ is the first FDA-Approved viral genetic test to detect nasopharyngeal cancer where other methods fail

  • Non-Invasive and office-based
  • Quick, Accurate, Painless
  • Exceptional sensitivity and specificity for early cancer detection
  • Innovative, life-saving technology
LEARN MORE ABOUT NP SCREEN™

NP SCREEN: THE FACTS

ACCURATE

With a sensitivity and specificity of 98% and 99% respectively, NP Screen excels at the detection of early, small cancer, submucosal growth, and cancer that may be missed by traditional tests or human error.

Z

FDA APPROVED

NP Screen has successfully met rigorous FDA standards and received Class II medical device classification. It is the first and currently only FDA-approved medical device for NPC detection.

 

ACCESSIBLE

NP Screen is a convenient, pain-free, non-invasive office-based procedure, available at multiple locations globally.

THE PROCESS

TESTING

  • Quick, in-office, anesthesia-free procedure
  • A physician or nurse practitioner takes a simple, painless swab of the nasopharynx
  • Cells are collected via NP Screen’s innovative trans-oral brushing process and sent for analysis

STORAGE & SHIPPING

  • The sample is secured in a vial containing a proprietary DNA preservation solution provided to your physician or nurse practitioner
  • The solution allows storage of the sample at room temperature with no DNA degradation
  • Samples are shipped by your provider to a designated FDA-approved lab

ANALYSIS & RESULTS

  • The sample is cataloged, sorted and prepared for processing at the lab
  • A proprietary lab assay protocol (real time Quantitative Polymerase Chain Reaction/Q-PCR) is used to detect the presence of EBV DNA from abnormal cells in the sample
  • Results are usually available within 3-5 business days after collection

THE PROFILE

%

SENSITIVITY

Sensitivity refers to the proportion of people with the disease who will have a positive result. A test with 100% sensitivity identifies 100% of people with the disease.

%

SPECIFICITY

 Specificity refers to the proportion of people without the disease who will have a negative result. A test with 100% specificity will identify 100% of patients who do not have the disease.

%

PPV

Positive Predictive Value (PPV) predicts the odds of having a disease if you have a positive result.

%

NPV

Negative Predictive Value (NPV) is the probability that a negative test result truly means you do not have the disease. It is the probability that a negative test result is accurate.

NP SCREEN & THE WORLD HEALTH ORGANIZATION

NP Screen is listed in the World Health Organization’s Compendium of innovative health technologies for low resource settings, 2011-2014 (p. 20).

Recognized as the gold standard in diagnostic testing, NP Screen scores exceptionally high on criteria that evaluate the value and success of a screening test.

ABOUT US

Dedicated. Dependable. Distinguished.

Developed by Advanced Sentry Corporation (ASC), NP Screen is the brainchild of an international team of surgeons, professors, scientists, and industry leaders, committed to the early detection of nasopharyngeal cancer, so survival rates can be significantly improved worldwide.

AM I AT RISK?

Viral infection, ethnic background, age, gender, environmental factors, and family history all contribute to the risk of developing nasopharyngeal cancer. Use our assessment tool to estimate your risk level so that early intervention, such as screening, can be initiated if appropriate.
RISK ASSESSMENT SURVEY

GET SCREENED TODAY

NP Screen a simple, in-office procedure that does not require a physician’s referral. It is available at multiple locations internationally.

Early detection saves lives.

 

FIND YOUR LOCAL NP Screen PROVIDER

WATCH THE VIDEO: